{"title":"In Vitro Binding of [3H]PSB-0413 to P2Y12 Receptors","authors":"Arnaud Dupuis, Véronique Heim, Philippe Ohlmann, Christian Gachet","doi":"10.1002/0471141755.ph0135s71","DOIUrl":null,"url":null,"abstract":"<p>The P2Y<sub>12</sub> /ADP receptor plays a central role in platelet activation. Characterization of this receptor is mandatory for studying disorders associated with a P2Y<sub>12</sub> receptor defect and for evaluating P2Y<sub>12</sub> receptor agonists and antagonists. In the absence of suitable anti-P2Y<sub>12</sub> antibodies, radioligand binding assays are the only way to conduct such studies. While various radioligands were employed in the past for this purpose, none were found to be suitable for routine use. Described in this unit are protocols for quantitatively and qualitatively assessing P2Y<sub>12</sub> receptors with [<sup>3</sup>H]PSB-0413, a selective antagonist for this site. The saturation and competition assays described herein make possible the determination of P2Y<sub>12</sub> receptor density on cells, as well as the potencies and affinities of test agents at this site. © 2015 by John Wiley & Sons, Inc.</p>","PeriodicalId":10871,"journal":{"name":"Current Protocols in Pharmacology","volume":"71 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2015-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/0471141755.ph0135s71","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Protocols in Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/0471141755.ph0135s71","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 2
Abstract
The P2Y12 /ADP receptor plays a central role in platelet activation. Characterization of this receptor is mandatory for studying disorders associated with a P2Y12 receptor defect and for evaluating P2Y12 receptor agonists and antagonists. In the absence of suitable anti-P2Y12 antibodies, radioligand binding assays are the only way to conduct such studies. While various radioligands were employed in the past for this purpose, none were found to be suitable for routine use. Described in this unit are protocols for quantitatively and qualitatively assessing P2Y12 receptors with [3H]PSB-0413, a selective antagonist for this site. The saturation and competition assays described herein make possible the determination of P2Y12 receptor density on cells, as well as the potencies and affinities of test agents at this site. © 2015 by John Wiley & Sons, Inc.
[3H]PSB-0413与P2Y12受体的体外结合
P2Y12 /ADP受体在血小板活化中起核心作用。该受体的表征对于研究与P2Y12受体缺陷相关的疾病以及评估P2Y12受体激动剂和拮抗剂是必需的。在缺乏合适的抗p2y12抗体的情况下,放射性配体结合试验是进行此类研究的唯一方法。虽然过去为此目的使用了各种放射性配体,但没有一种适合常规使用。本单元描述了使用[3H]PSB-0413(该位点的选择性拮抗剂)定量和定性评估P2Y12受体的方案。本文所述的饱和和竞争试验可以测定细胞上P2Y12受体的密度,以及测试剂在该位点的效力和亲和力。©2015 by John Wiley &儿子,Inc。
本文章由计算机程序翻译,如有差异,请以英文原文为准。